Sinopep-Allsino Biopharmaceutical Co. Ltd. A
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China. The company offers Peptide CDMO Services,GMP oligo, full-time equivalent, discovery, generic APIs, and formulation services. It is also involved in professional technical services. The company was… Read more
Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.022x
Based on the latest financial reports, Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) has a cash flow conversion efficiency ratio of 0.022x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥68.66 Million) by net assets (CN¥3.13 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sinopep-Allsino Biopharmaceutical Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Sinopep-Allsino Biopharmaceutical Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sinopep-Allsino Biopharmaceutical Co. Ltd. A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sinopep-Allsino Biopharmaceutical Co. Ltd. A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tansun Technology Co Ltd
SHE:300872
|
0.019x |
|
Banca IFIS S.p.A.
LSE:0NBX
|
-0.005x |
|
Jiangsu Shentong Valve Co Ltd
SHE:002438
|
0.028x |
|
Zhengzhou GL Tech Co Ltd
SHE:300480
|
-0.004x |
|
KRUNGTHAI CARD FGN BA 1
F:KRTA
|
N/A |
|
Global Power Synergy Public Company Limited
BK:GPSC-R
|
0.064x |
|
Yantai China Pet Foods Co Ltd
SHE:002891
|
0.000x |
|
KPC Pharmaceuticals Inc
SHG:600422
|
-0.002x |
Annual Cash Flow Conversion Efficiency for Sinopep-Allsino Biopharmaceutical Co. Ltd. A (2013–2024)
The table below shows the annual cash flow conversion efficiency of Sinopep-Allsino Biopharmaceutical Co. Ltd. A from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.68 Billion | CN¥400.12 Million | 0.149x | -6.75% |
| 2023-12-31 | CN¥2.19 Billion | CN¥350.21 Million | 0.160x | +951.19% |
| 2022-12-31 | CN¥1.92 Billion | CN¥29.29 Million | 0.015x | -84.77% |
| 2021-12-31 | CN¥1.81 Billion | CN¥180.75 Million | 0.100x | -31.72% |
| 2020-12-31 | CN¥966.02 Million | CN¥141.38 Million | 0.146x | +166.14% |
| 2019-12-31 | CN¥838.98 Million | CN¥46.14 Million | 0.055x | -55.04% |
| 2018-12-31 | CN¥785.38 Million | CN¥96.06 Million | 0.122x | +253.60% |
| 2017-12-31 | CN¥321.20 Million | CN¥11.11 Million | 0.035x | +105.51% |
| 2016-12-31 | CN¥34.95 Million | CN¥-21.95 Million | -0.628x | +59.12% |
| 2015-12-31 | CN¥73.32 Million | CN¥-112.62 Million | -1.536x | +51.62% |
| 2014-12-31 | CN¥-21.47 Million | CN¥68.18 Million | -3.175x | -126.79% |
| 2013-12-31 | CN¥3.69 Million | CN¥43.67 Million | 11.850x | -- |